Development of Matrix Metalloproteinase-2 Inhibitors for Cardioprotection-Reference-Cited by-同舟云学术

Development of Matrix Metalloproteinase-2 Inhibitors for Cardioprotection

Published:2018-04-05 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Bencsik Péter,Kupai Krisztina,Görbe Anikó,Kenyeres Éva,Varga Zoltán V.,Pálóczi János,Gáspár Renáta,Kovács László,Weber Lutz,Takács Ferenc,Hajdú István,Fabó Gabriella,Cseh Sándor,Barna László,Csont Tamás,Csonka Csaba,Dormán György,Ferdinandy Péter

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference49 articles.

1. Structural exploration for the refinement of anticancer matrix metalloproteinase-2 inhibitor designing approaches through robust validated multi-QSARs;Adhikari;J. Mol. Struct.,2018

2. Fragment-based discovery of 5-Arylisatin-based inhibitors of matrix metalloproteinases 2 and 13;Agamennone;ChemMedChem,2016

3. Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury;Ali;Circulation,2010

4. Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors;Almstead;J. Med. Chem.,1999

5. Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries;Alwan;Lancet,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fenofibrate Induces a Resolving Profile in Heart Macrophage Subsets and Attenuates Acute Chagas Myocarditis;ACS Infectious Diseases;2024-04-22

2. ‘Outside-the-box’ therapeutic solutions for ischaemia–reperfusion myocardial protection;European Heart Journal. Acute Cardiovascular Care;2023-03-01

3. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning;Pharmacological Reviews;2022-12-08

4. A review of MMP-2 structures and binding mode analysis of its inhibitors to strategize structure-based drug design;Bioorganic & Medicinal Chemistry;2022-11

5. Matrix Metalloproteinase 2 as a Pharmacological Target in Heart Failure;Pharmaceuticals;2022-07-25